Avital Rand

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2007 · 106 citations

Medicine, Hematology, Immunology +16

Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 51 citations

Medicine, Oncology, Pharmacology +17

Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors

Olga Ostrovsky, Avichai Shimoni, Avital Rand et al. · Blood · 2010 · 51 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma

Avichai Shimoni, S.T. Zwas, Yakov Oksman et al. · Bone Marrow Transplantation · 2007 · 46 citations

Medicine, Oncology, Pharmacotherapy +16